ResMed Inc. vs Rockwell Automation — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Rockwell Automation trades at $466.05 (market cap $51.04B). The key difference: Rockwell Automation is the larger of the two by market cap, and ResMed Inc. pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| RMD | ROK | |
|---|---|---|
Market Cap | $28.81B | $51.04B |
Sector | Health | Industrials |
52-Week High | $293.73 | $495.08 |
52-Week Low | $182.82 | $328.67 |
Enterprise Value | $27.99B | $54.67B |
Dividend Yield | 1.21% | 1.2% |
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →